Dorzox (Dorzolamide) 2% Eye Drop 5ml bottle
Active ingredient | Dorzolamide 2% w/v |
---|---|
Dispensing Country | India |
Medicine Description:
Dorzolamide Eye Drop is a medication used to lower intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. It belongs to the class of drugs known as carbonic anhydrase inhibitors, which work by reducing the production of aqueous humor in the eye, thereby decreasing eye pressure.
Uses & Benefits:
Dorzolamide Eye Drop is primarily used to manage elevated intraocular pressure (IOP) associated with open-angle glaucoma or ocular hypertension. By lowering eye pressure, it helps prevent optic nerve damage and vision loss in patients with these conditions.
Best Condition to Use Medicine:
Dorzolamide Eye Drop is best suited for individuals diagnosed with open-angle glaucoma or ocular hypertension, conditions characterized by increased intraocular pressure. It is prescribed by ophthalmologists or healthcare professionals to manage these conditions and prevent vision loss.
Dosage:
The dosage of Dorzolamide Eye Drop may vary depending on the severity of glaucoma or ocular hypertension and the patient's response to treatment. Typically, one drop is instilled into the affected eye(s) three times daily, or as directed by a healthcare professional.
Direction/Instructions for Use:
-
Wash your hands thoroughly before using the eye drops.
-
Shake the bottle well before each use.
-
Tilt your head back and gently pull down the lower eyelid to create a small pocket.
-
Hold the dropper directly over the eye and instill the prescribed number of drops into the pocket without touching the dropper tip to the eye or surrounding area.
-
Close your eyes for a few moments and gently press on the inner corner of the eye to prevent the medication from draining out.
-
Wipe any excess medication from the skin around the eye.
-
If using other eye medications, wait at least 10 minutes before instilling them to prevent dilution and ensure proper absorption.
Instructions for Use During Pregnancy:
Pregnant individuals should consult their healthcare provider before using Dorzolamide Eye Drop. While there are limited studies on its safety during pregnancy, the potential benefits and risks should be carefully considered before use.
Food & Drug Interaction:
Dorzolamide Eye Drop may interact with certain medications, including other carbonic anhydrase inhibitors, such as acetazolamide, and medications that affect kidney function, such as lithium. It is important to inform your healthcare provider about all medications, supplements, and herbal products you are taking to avoid potential interactions.
Most Frequently Asked Questions:
-
What is Dorzolamide Eye Drop used for? Dorzolamide Eye Drop is used to lower intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension.
-
How often should I use Dorzolamide Eye Drop? The frequency of use depends on the severity of glaucoma or ocular hypertension and the patient's response to treatment. It is usually administered three times daily, or as directed by a healthcare professional.
-
Can Dorzolamide Eye Drop be used in children? Dorzolamide Eye Drop can be used in children, but the dosage should be adjusted according to their age and weight. Pediatric use should be under the supervision of a healthcare professional.
-
What are the common side effects of Dorzolamide Eye Drop? Common side effects may include temporary stinging or burning sensation in the eyes, blurred vision, dry eyes, and bitter taste in the mouth. These side effects are usually mild and transient.
-
How long does it take for Dorzolamide Eye Drop to work? Improvement in intraocular pressure is typically observed within a few hours of starting treatment with Dorzolamide Eye Drop. However, maximum therapeutic effect may take several weeks of regular use.
-
Can Dorzolamide Eye Drop be used while wearing contact lenses? Contact lenses should be removed before using Dorzolamide Eye Drop and may be reinserted after 15 minutes. Consult your eye care professional for further guidance.